Drug archive
Troglitazone (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antidiabetic agent
Description
Troglitazone (TROE-glit-a-zone) is used to treat a certain type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It may be used with insulin, or with a type of oral diabetes medicine called a sulfonylurea, or with a sulfonylurea and metformin.
This medicine was withdrawn from the U.S. market in March 2000.